Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Investigating the Frequency of the ERCC1 Gene C8092A Polymorphism in Iranian Patients with Advanced Gastric Cancer Receiving Platinum-based Chemotherapy.

Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2016

Mokmeli Sharareh, Tehrani Golnaz Asaadi, Zamiri Reza Eghdam, Bahrami Tayyeb

Abstract excerpt

BACKGROUND: Platinum compounds are the main drugs for treatment of advanced gastric cancer. Previous studies have shown that clinical outcome with platinum-based compounds depends on ERCC1 polymorphisms. The aim of this study was to investigate the frequency of a common polymorphism of ERCC1 gene (C8092A) in Iranian patients with advanced gastric cancer receiving platinum chemotherapy. MATERIALS AND METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Endonucleases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Neoplasm Grading

Share to Platinum Compounds

Share to Polymorphism, Restriction Fragment Length

Share to Stomach Neoplasms

Share to Survival Rate

Source

Identifiers

PMID: 27039774
DOI: 10.7314/apjcp.2016.17.3.1369

Genes

ERCC1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Investigating the Frequency of the ERCC1 Gene C8092A Polymorphism in Iranian Patients with Advanced Gastric Cancer Receiving Platinum-based Chemotherapy.PMID 27039774Read ↗

Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.Semantic proximity Read ↗

Predictive Value of Excision Repair Cross-Complementation Group 1 in the Response to Platinum-Based Chemotherapy in Esophageal Cancer: A Meta-Analysis.Semantic proximity Read ↗

Predicting the outcome of platinum-based chemotherapies in epithelial ovarian cancer using the 8092C/A polymorphism of ERCC1: a meta-analysis.Semantic proximity Read ↗

Genetic polymorphisms of DNA repair pathways influence the response to chemotherapy and overall survival of gastric cancer.Semantic proximity Read ↗

Genetic variability of ERCC1 and ERCC2 influences treatment outcomes in gastric cancer.Semantic proximity Read ↗

ERCC1, XRCC1, and GSTP1 Polymorphisms and Treatment Outcomes of Advanced Epithelial Ovarian Cancer Patients Treated with Platinum-based Chemotherapy.Semantic proximity Read ↗

Genetic variability of DNA repair mechanisms influences chemotherapy outcome of gastric cancer.Semantic proximity Read ↗

Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer.Semantic proximity Read ↗

Association of ERCC1 SNPs with outcome in platinum-treated patients with advanced urothelial cancer: a Hellenic Cooperative Oncology Group study.Semantic proximity Read ↗

Association between polymorphisms of ERCC1 and survival in epithelial ovarian cancer patients with chemotherapy.Semantic proximity Read ↗

Genetic variability of ERCC1 genes in NER pathway influences the treatment outcome of gastric cancer.Semantic proximity Read ↗

Impact of ERCC1 gene polymorphisms on response to cisplatin based therapy in oral squamous cell carcinoma (OSCC) patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.